{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:47Z","timestamp":1788754127580,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T00:00:00Z","timestamp":1368576000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s40273-013-0057-2","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T11:17:44Z","timestamp":1368530264000},"page":"563-576","source":"Crossref","is-referenced-by-count":26,"title":["The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review"],"prefix":"10.1007","volume":"31","author":[{"given":"Andrea","family":"Anonychuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Demarteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"key":"57_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2334-10-175","volume":"10","author":"VN Racloz","year":"2010","unstructured":"Racloz VN, Luiz SJ. The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect Dis. 2010;10:175.","journal-title":"BMC Infect Dis"},{"issue":"19","key":"57_CR2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/archinte.159.19.2329","volume":"159","author":"N Barquet","year":"1999","unstructured":"Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al. Meningococcal disease in a large urban population (Barcelona, 1987\u20131992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med. 1999;159(19):2329\u201340.","journal-title":"Arch Intern Med"},{"issue":"2 Suppl","key":"57_CR3","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.2223\/JPED.1612","volume":"83","author":"RG Branco","year":"2007","unstructured":"Branco RG, Amoretti CF, Tasker RC. Meningococcal disease and meningitis. J Pediatr (Rio J). 2007;83(2 Suppl):S46\u201353.","journal-title":"J Pediatr (Rio J)"},{"issue":"7312","key":"57_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.323.7312.533","volume":"323","author":"H Bedford","year":"2001","unstructured":"Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5\u00a0years. BMJ. 2001;323(7312):533\u20136.","journal-title":"BMJ"},{"issue":"5","key":"57_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","volume":"10","author":"K Edmond","year":"2010","unstructured":"Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"57_CR6","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","volume":"29","author":"LH Harrison","year":"2011","unstructured":"Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, et al. The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29(18):3363\u201371.","journal-title":"Vaccine"},{"issue":"12","key":"57_CR7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"57_CR8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/648964","volume":"50","author":"GA Poland","year":"2010","unstructured":"Poland GA. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Clin Infect Dis. 2010;50(Suppl 2):S45\u201353.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"57_CR9","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","volume":"27","author":"LH Harrison","year":"2009","unstructured":"Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51\u201363.","journal-title":"Vaccine"},{"issue":"3","key":"57_CR10","first-page":"177","volume":"3","author":"D O\u2019Donovan","year":"2000","unstructured":"O\u2019Donovan D, Iversen A, Trounce J, Curtis S. Outbreak of group C meningococcal infection affecting two preschool nurseries. Commun Dis Public Health. 2000;3(3):177\u201380.","journal-title":"Commun Dis Public Health"},{"key":"57_CR11","unstructured":"World Health Organization. Health topics: disease outbreaks. http:\/\/www.who.int\/topics\/disease_outbreaks\/en\/ . 2011. Cited 1 Jan 2010."},{"issue":"1","key":"57_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/504804","volume":"43","author":"R Brooks","year":"2006","unstructured":"Brooks R, Woods CW, Benjamin DK Jr, Rosenstein NE. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994\u20132002. Clin Infect Dis. 2006;43(1):49\u201354.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"57_CR13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.1995.03520290035026","volume":"273","author":"LA Jackson","year":"1995","unstructured":"Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. 1995;273(5):383\u20139.","journal-title":"JAMA"},{"issue":"4","key":"57_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2105\/AJPH.88.4.685","volume":"88","author":"CC Austin","year":"1998","unstructured":"Austin CC, Fingar AR, Langkop C. Outbreak of serogroup C meningococcal disease among preschool-aged children: Illinois, 1996. Am J Public Health. 1998;88(4):685.","journal-title":"Am J Public Health"},{"issue":"Suppl 2","key":"57_CR15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0033-3549(04)50147-4","volume":"116","author":"MT Osterholm","year":"2001","unstructured":"Osterholm MT. How to vaccinate 30,000 people in three days: realities of outbreak management. Public Health Rep. 2001;116(Suppl 2):74\u20138.","journal-title":"Public Health Rep"},{"issue":"7","key":"57_CR16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1086\/597257","volume":"48","author":"D Weiss","year":"2009","unstructured":"Weiss D, Stern EJ, Zimmerman C, Bregman B, Yeung A, Das D, et al. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Clin Infect Dis. 2009;48(7):894\u2013901.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"57_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/hv.7.2.14068","volume":"7","author":"N Bermal","year":"2011","unstructured":"Bermal N, Huang LM, Dubey AP, Jain H, Bavdekar A, Lin TY, et al. Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults. Hum Vaccin. 2011;7(2):239\u201347.","journal-title":"Hum Vaccin"},{"issue":"7","key":"57_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","volume":"8","author":"CL Trotter","year":"2009","unstructured":"Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009;8(7):851\u201361.","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"57_CR19","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/INF.0b013e31820e6e02","volume":"30","author":"ZA Memish","year":"2011","unstructured":"Memish ZA, Dbaibo G, Montellano M, Verghese VP, Jain H, Dubey AP, et al. Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile. Pediatr Infect Dis J. 2011;30(4):e56\u201362.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"57_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","volume":"159","author":"H Keyserling","year":"2005","unstructured":"Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159(10):907\u201313.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"57_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","volume":"24","author":"M Pichichero","year":"2005","unstructured":"Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, et al. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide\u2013diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pediatr Infect Dis J. 2005;24(1):57\u201362.","journal-title":"Pediatr Infect Dis J"},{"key":"57_CR22","doi-asserted-by":"crossref","unstructured":"Patel M, Lee CK. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. Cochrane Database Syst Rev. 2005;(1):CD001093.","DOI":"10.1002\/14651858.CD001093.pub2"},{"key":"57_CR23","unstructured":"World Health Organization. Cost of reactive campaigns: a reactive vaccination campaign is expensive and provides no long-term protection. http:\/\/www.meningvax.org\/financial-impact.php . 2012. Cited 1 Jan 2011."},{"key":"57_CR24","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"issue":"3","key":"57_CR25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1017\/S0266462304001096","volume":"20","author":"D Getsios","year":"2004","unstructured":"Getsios D, Caro I, El-Hadi W, Caro JJ. Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research. Int J Technol Assess Health Care. 2004;20(3):280\u20138.","journal-title":"Int J Technol Assess Health Care"},{"key":"57_CR26","unstructured":"The World Bank. Country and Lending Groups. http:\/\/data.worldbank.org\/about\/country-classifications\/country-and-lending-groups#Low_income . 2011. Cited 1 Jan 2010."},{"key":"57_CR27","unstructured":"Organisation for Economic Co-operation and Development. Purchasing power parities (PPP). http:\/\/www.oecd.org\/...\/0,3746,en_2649_34347_45854149_1_1_1_1,00.html . 2011. Cited 1 Jan 2010."},{"key":"57_CR28","unstructured":"United States Department of Labor. Consumer price index. http:\/\/www.bls.gov\/cpi\/ . 2011. Cited 1 Jan 2010."},{"issue":"3","key":"57_CR29","first-page":"343","volume":"110","author":"P Houck","year":"1995","unstructured":"Houck P, Patnode M, Atwood R, Powell K. Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response. Public Health Rep. 1995;110(3):343\u20139.","journal-title":"Public Health Rep"},{"issue":"10","key":"57_CR30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/00006454-199510000-00017","volume":"14","author":"A Banerji","year":"1995","unstructured":"Banerji A, King WJ, MacDonald N, Li M. Use of single dose ceftriaxone in the emergency department during an outbreak of serogroup C meningococcal disease. Pediatr Infect Dis J. 1995;14(10):904\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"57_CR31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/oxfordjournals.pubmed.a024604","volume":"19","author":"DJ Irwin","year":"1997","unstructured":"Irwin DJ, Miller JM, Milner PC, Patterson T, Richards RG, Williams DA, et al. Community immunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995\u20131996. J Public Health Med. 1997;19(2):162\u201370.","journal-title":"J Public Health Med"},{"issue":"15","key":"57_CR32","first-page":"122","volume":"24","author":"O Tolomeo","year":"1998","unstructured":"Tolomeo O, Buffett C, Richardson E. Management of a cluster of cases of invasive group C Neisseria meningitidis infections in the Hamilton-Wentworth region\u2014Ontario. Can Commun Dis Rep. 1998;24(15):122\u20136.","journal-title":"Can Commun Dis Rep"},{"issue":"12","key":"57_CR33","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3201\/eid0812.010421","volume":"8","author":"G Krause","year":"2002","unstructured":"Krause G, Blackmore C, Wiersma S, Lesneski C, Gauch L, Hopkins RS. Mass vaccination campaign following community outbreak of meningococcal disease. Emerg Infect Dis. 2002;8(12):1398\u2013403.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"57_CR34","first-page":"121","volume":"25","author":"P Robinson","year":"2001","unstructured":"Robinson P, Taylor K, Tallis G, Carnie J, Rouch G, Griffith J, et al. An outbreak of serogroup C meningococcal disease associated with a secondary school. Commun Dis Intell. 2001;25(3):121\u20135.","journal-title":"Commun Dis Intell"},{"issue":"8","key":"57_CR35","first-page":"569","volume":"121","author":"F Renevey","year":"2001","unstructured":"Renevey F, Demierre G, Chuard C, Regamey C. Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001. Rev Med Suisse Romande. 2001;121(8):569\u201372.","journal-title":"Rev Med Suisse Romande"},{"issue":"1","key":"57_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0035-9203(97)90371-0","volume":"91","author":"F Varaine","year":"1997","unstructured":"Varaine F, Caugant DA, Riou JY, Konde MK, Soga G, Nshimirimana D, et al. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg. 1997;91(1):3\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"57_CR37","unstructured":"da Silva A, Parent dC I, Beckr GA, Dompnier JP, Seck I. Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997. Sante. 2003;13(4):215\u201323."},{"issue":"9417","key":"57_CR38","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(04)16034-0","volume":"363","author":"K Ahmad","year":"2004","unstructured":"Ahmad K. Vaccination halts meningitis outbreak in Burkina Faso. Lancet. 2004;363(9417):1290.","journal-title":"Lancet"},{"key":"57_CR39","unstructured":"Siegel B. Meningitis outbreak: mother nature sends a scary message. Med Econ. 1995;72(16):173\u201380, 185."},{"issue":"6","key":"57_CR40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/oxfordjournals.aje.a008792","volume":"143","author":"PB Imrey","year":"1996","unstructured":"Imrey PB, Jackson LA, Ludwinski PH, England AC 3rd, Fella GA, Fox BC, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol. 1996;143(6):624\u201330.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"57_CR41","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/JCM.33.8.2209-2211.1995","volume":"33","author":"MB Edmond","year":"1995","unstructured":"Edmond MB, Hollis RJ, Houston AK, Wenzel RP. Molecular epidemiology of an outbreak of meningococcal disease in a university community. J Clin Microbiol. 1995;33(8):2209\u201311.","journal-title":"J Clin Microbiol"},{"key":"57_CR42","unstructured":"Oakes P. Meningococcal outbreak. Miss Morb Rep. 1991;9:1."},{"key":"57_CR43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00019048-199403000-00022","volume":"3","author":"JD Wenger","year":"1994","unstructured":"Wenger JD, Jackson LA, Raj P, Tonelli MJ. Issues in the control of outbreaks of group C meningococcal disease in the United States. Infect Dis Clin Pract. 1994;3:136\u201340.","journal-title":"Infect Dis Clin Pract"},{"issue":"2","key":"57_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00019053-200523020-00006","volume":"23","author":"P Jacobs","year":"2005","unstructured":"Jacobs P, Ohinmaa A, Brady B. Providing systematic guidance in pharmacoeconomic guidelines for analysing costs. Pharmacoeconomics. 2005;23(2):143\u201353.","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"57_CR45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/11535280-000000000-00000","volume":"28","author":"TL Kauf","year":"2010","unstructured":"Kauf TL. Methodological concerns with economic evaluations of meningococcal vaccines. Pharmacoeconomics. 2010;28(6):449\u201361.","journal-title":"Pharmacoeconomics"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-013-0057-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-013-0057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-013-0057-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T18:45:05Z","timestamp":1595789105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-013-0057-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,15]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s40273-013-0057-2","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,15]]}}}